… This study further illustrates that uncommon EGFR mutations are highly heterogeneous and
compound mutations are common in patients with EGFR mutation-positive NSCLC. However…

… Therefore, more large-scale cohort studies and data in this field should be welcomed to …
with uncommon EGFR mutations in this study is relatively high compared with other studies, …

… light on new treatment options for patients of EGFR exon 20 insertion mutation. In our study,
patients of the type-II uncommon EGFR mutation exhibited a bipolar tumour behaviour, with …

… of treatment options for the current uncommon EGFR mutations. Our results indicate that
the … In smaller cohorts, EGFR mutation status and response rates have been reported, but …

… Given the low patient numbers in uncommon EGFR mutation cohorts in individual studies,
it is valuable to examine the breadth of evidence across studies; consequently, our SLR was …

… The specific types of uncommon EGFR mutations detected in this analysis are described
in Table 2. The most frequent EGFR mutations were G719X and L861Q, detected in 6 (17.2%) …

… Multiple uncommon EGFR mutations or an uncommon EGFR … a cohort of Dutch (ie,
predominant Caucasian) EGFR-mutated NSCLC patients retrospectively. The purpose of this study …

… uncommon EGFR mutations in a real-world setting. Therefore, in this study, we conducted
a real-world, ambispective cohort study … NSCLC patients with uncommon EGFR mutations. …

… uncommon EGFR mutations and summarizes reported outcomes when treated with EGFR-TKIs.
… However, as stated previously, the S768I EGFR mutation cohort contained 8 patients in …

… This was a comparative cohort study in two … uncommon EGFR mutations treated with afatinib
or dacomitinib were eligible for evaluation. Two cohorts were employed in the current study. …